Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. - Wikidata - awgldk - TriplyDB

Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

http://www.wikidata.org/entity/Q34651434

about

Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model HIV-1 Vif, APOBEC, and intrinsic immunity Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all The APOBEC3 family of retroelement restriction factors Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Structural Insights into HIV-1 Vif-APOBEC3F Interaction NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity APOBEC3G: an intracellular centurion Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.Nanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA.AID and Apobec3G haphazard deamination and mutational diversity Free Energy Profile of APOBEC3G Protein Calculated by a Molecular Dynamics Simulation T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.APOBEC3G inhibits elongation of HIV-1 reverse transcripts.Functions and regulation of the APOBEC family of proteins Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.Stably expressed APOBEC3F has negligible antiviral activity.Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.APOBEC4 Enhances the Replication of HIV-1.Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G The role of BST2/tetherin in feline retrovirus infection Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase.Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.APOBEC3 inhibits DEAD-END function to regulate microRNA activity APOBEC3G: a double agent in defense Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.APOBEC deaminases-mutases with defensive roles for immunity.

P2860

Q21131577-C8A84EC2-903B-44B4-82BE-20D93278901A Q21245195-D9DF83E6-C4E9-4A3D-AE28-D244BC9D2A96 Q24565021-34CC639E-C7C3-4814-8CDE-4557D11FBB78 Q24615552-DB219A37-DE4B-4F98-873D-0A66E99C036C Q24619114-DB5A05D1-C006-4ACA-A880-857DE1C57724 Q24642268-78496187-903F-4F58-AFA3-B5F6CC7E300F Q24647833-743A4246-668D-4334-9C8F-A175AD784F26 Q26823568-C2319EC6-210F-4C27-A361-FA8626B96660 Q26862780-CF77FC15-0FCA-479C-834D-3B73BD2CD52F Q27025150-DC4602CB-7DAB-45BC-805B-B9142F5BE2D3 Q27321018-11741EC9-A0BA-4D3E-8490-8F1F55EAB16D Q27678249-E11CA769-6137-4CF0-868B-B74ACECAE9E2 Q28754989-27B02D0F-A842-4D85-8331-B90D9C6C6187 Q30381745-6B73801E-E212-43FD-868D-2C2D9EC480D6 Q30483676-3A9EDF61-8913-4F72-84B1-28555C752F44 Q30525163-443BA1CC-8BCF-410B-B472-67D48780C7A5 Q30537745-0980F1C5-E31C-43B5-BDB5-34B13F83BBBB Q30821565-5E2B3588-CE30-405C-A946-9025616F21A5 Q33300132-A0945E18-F7BD-4234-86CE-A524D41FA3AC Q33349452-2A070FB1-66E2-42FB-84EE-019C75BAE435 Q33385376-E52B06CA-A35F-49C5-B752-A81075F65E0A Q33389841-8B81ED17-693A-41DA-A9E0-7F26B006215A Q33595661-98B83F2B-462E-4D2E-8327-30EB57A5D64A Q33602923-FFED43C1-0441-40C5-95FB-CC5E70404B2B Q33634092-29FE2E32-B883-418A-96BD-1A2E3A28C20A Q33654949-471ECF74-7466-479E-A9E2-6DED466371E4 Q33826968-8B54FD40-AEB3-473D-94D6-4F4F5492A5E4 Q33878087-3F54395C-7FB5-416E-A75C-19F541665F61 Q34052968-A4B9A0FD-F291-4A76-B13D-264F0C7B890B Q34190587-0B703FA5-70F5-462A-91F8-C1F025464108 Q34416419-8A1B733B-8131-47D4-87BF-D1C0DBB96200 Q34529142-87F4C312-C965-45FF-9439-F9FE92AE1B77 Q34536866-C7563B83-B354-495A-BFAD-16A472DF3539 Q34664616-387B2443-3CFF-4333-B26F-E56C11B372CD Q34745411-5BCF1795-17F4-4EFA-A9EB-FCF59FAE447E Q34775658-E6979592-3AB3-4D3F-8992-A09111A79D4E Q34868689-843C7576-E716-444B-ACC2-148FDE18759E Q34917194-F51FB1DB-C6D8-4DAF-A2BD-A7C60B3B361E Q34972927-A13D924B-C8A3-4E4E-946F-54D2B5052B6C Q35012747-ACF57EF3-30E7-4251-88DE-37F15F58A0B5

P2860

Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

http://www.wikidata.org/entity/Q34651434

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Biochemical activities of high ...... elation with antiviral effect.

@ast

Biochemical activities of high ...... elation with antiviral effect.

@en

Biochemical activities of high ...... elation with antiviral effect.

@nl

type

label

Biochemical activities of high ...... elation with antiviral effect.

@ast

Biochemical activities of high ...... elation with antiviral effect.

@en

Biochemical activities of high ...... elation with antiviral effect.

@nl

prefLabel

Biochemical activities of high ...... elation with antiviral effect.

@ast

Biochemical activities of high ...... elation with antiviral effect.

@en

Biochemical activities of high ...... elation with antiviral effect.

@nl

P1433

Q34651434-71A109AA-E77F-4383-8EEE-9ED8E1B9529A

P1476

Q34651434-274CE75D-C760-4275-9E1D-815A13154C17

P2093

Q34651434-80CC3AA6-951F-4CC6-8D91-23B56AAC5CEA

Q34651434-C85F3567-DB1E-4EF3-B645-8C8F6A760460

Q34651434-CBC57952-57C2-4DFF-9CD5-3E23A32F3372

P2860

Q34651434-01CDC6B4-0C81-4363-918F-D91DB991F071

Q34651434-03D571ED-4B7E-4D95-B02E-9E70212E0800

Q34651434-085C738D-41C3-49D7-AE42-7AD6E7A4A20D

Q34651434-09C40D5A-E3B4-4DC6-9103-2209059A1544

Q34651434-0B3F68C7-0639-4086-8E40-BACC7CABE0C8

Q34651434-0B7750CF-3AAC-4570-BF45-0F862F33EDC8

Q34651434-0C9E3F87-AE4A-437C-8284-68A80A203445

Q34651434-105372EA-60F3-43FE-AAF8-F52CB5C4CD12

Q34651434-150435C3-CB9A-487D-AA32-DD790293C471

Q34651434-1B042483-F5E7-4508-BA8F-D8B198A5D165

P304

Q34651434-4F14509E-C936-4E74-B567-30146FE3F919

P31

Q34651434-72FBB074-71A1-4394-AA0E-162636B45435

P356

Q34651434-D4D11D85-686F-4C76-8550-E4265CFBE5D3

P407

Q34651434-3098DF84-2D00-48B3-80BB-EE37F1E03D67

P433

Q34651434-4D1C1AE9-44E0-42A1-B65D-1682BC158E98

P478

Q34651434-D43B0520-DCEB-41B8-B3BE-54D609933650

P50

Q34651434-6672BF4C-8467-4592-AE7B-66A7A0C9FEB7

P577

Q34651434-B1BD43D4-6F45-493E-A3A0-6C48031A002F

P698

Q34651434-DC6804BC-3DA7-4707-8516-AC71634683D4

P932

Q34651434-1E562A47-85F5-4D6C-B06D-8231812A8C94

P356

P1433

Journal of Virology

P1476

Biochemical activities of high ...... relation with antiviral effect

@en

P2093

Hiroaki Takeuchi

http://www.w3.org/2001/XMLSchema#string

Judith G Levin

http://www.w3.org/2001/XMLSchema#string

Klaus Strebel

http://www.w3.org/2001/XMLSchema#string

P2860

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

DNA deamination mediates innate immunity to retroviral infection

P304

5992-6002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02680-05

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Yasumasa Iwatani

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16731938

http://www.w3.org/2001/XMLSchema#string

P932

1472592

http://www.w3.org/2001/XMLSchema#string